In people with diabetes, low levels of IGFBP-1 predicted future cardiovascular risk [13], and in a prospective study of non-diabetics at baseline, high levels of IGFBP-1 reduced the risk of developing insulin resistance or type 2 diabetes during a 10-year time span [14]. The gene discussed is IGFBP1; the disease is type 2 diabetes mellitus.